$ABCL

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$ABCLSEC Form 4bullish

Booth Andrew · Chief Financial Officer at AbCellera Biologics Inc. · 47d agono track record yet

Long 37,200 shares of ABCL

Bought 37,200 @ $10.32 avg · $383,904 · 2026-08-14

Form 4: Booth Andrew bought ABCL

Booth Andrew (Chief Financial Officer at AbCellera Biologics Inc.) reported an open-market purchase of 37,200 shares of ABCL at an average $10.32, roughly $383,904, in a Form 4 filed 2026-08-14.

At post $11.38Now $12.63+11.0% since postedas of Sep 18, 4:30 PM ET

1d—

3d-1.6%

1w-0.5%

1m-4.3%

3m—

6m—

1y—

View filing on SEC.gov →

$ABCLSEC Form 4bullish

Hayden Michael R · AbCellera Biologics Inc. · 47d agono track record yet

Long 46,387 shares of ABCL

Bought 46,387 @ $10.37 avg · $481,033 · 2026-08-12

Form 4: Hayden Michael R bought ABCL

Hayden Michael R (Director at AbCellera Biologics Inc.) reported an open-market purchase of 46,387 shares of ABCL at an average $10.37, roughly $481,033, in a Form 4 filed 2026-08-14.

At post $11.38Now $12.63+11.0% since postedas of Sep 18, 4:30 PM ET

1d—

3d-1.6%

1w-0.5%

1m-4.3%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.